All Access

Health Tech Deals

Health Tech Deals Alerts

Alert

Standard

Health Tech Deals Thought Bubble

Thought Bubble

mustard

BFD Expert Voices - Health Tech Deals

BFD Expert Voices

As the AI hype cycle rages on, the question of user experience is becoming increasingly important, health care dealmakers said at the Axios BFD yesterday.

Why it matters: Companies can spend millions developing new AI tools, but it's all moot if physicians and patients can't practically use them.

The big picture: Health care is no stranger to AI. Use cases span clinical documentation to flagging potential medical issues in patients based on electronic health record data.

Yes, but: Not all algorithms are created equal.

What they're saying: "I'm a physician, I'm an ICU doc, and I can't tell you how many times I have these pop-ups [in our EMR] that are completely irrelevant," said Abridge chief clinical officer Tina Shah, speaking at the BFD's Health Tech Expert Voices roundtable.

"Like, 'Your patient's dying of septic shock' — and they're totally fine and talking to you," she added. "We've already lost trust. We now need to prove trust. "

And when it comes to evaluating the safety and efficacy of AI tools, "we need more than a white paper," said Atropos Health CEO Brigham Hyde.

"We have to up our game," Hyde added. "We can't ... just throw something out in health care that hurts people and then gets more people to leave the workforce."

Meanwhile, a lack of clear guidelines and regulation of AI further adds to the murkiness of utility, the speakers said — the FDA's newly established digital health advisory committee notwithstanding.

"The question is, who's going to [regulate]?" says Vytalize Health chief medical officer Amer Alnajar. " You have social media CEOs coming up and you have senators asking them, 'Is it true that Facebook uses Wi-Fi?'"

While Congress may not be up for the task, Hyde noted a progressive FDA and Shah suggested public-private partnerships as ways to accelerate more oversight.

Between the lines: AI models are only as good as the data they're trained on — and mitigating potential bias can be tricky.

"The bigger question is, 'What is the right data?'" said Oak HC/FT partner Vignesh Chandramouli. "Was it a good physician who did the medical record or a bad physician?"

Hyde and Brightside Health chief clinical officer Mimi Winsberg said their companies currently score datasets for appropriateness based on their applicability to a given population, question or treatment.

Be smart: Quality questions aside, there's no denying the speed at which AI can synthesize new clinical study information, said Alnajar.

"Medical research doubles every 72 days," he said. "Can anyone on this table double their clinical knowledge in 72 days? I don't think so."

Health care dealmakers talk end-user for AI

Companies can spend millions developing new AI tools, but it's all moot if physicians and patients can't practically use them.

(From left) Belwadi Srikanth of Suki; Dave Kerwar of Inbound Health; Kevin Davies of Mizuho Securities; Brigham Hyde of Atropos Health; and Amer Alnajar of Vytalize Health.  Photo: Beatrice Moritz

Artificial intelligence

As the AI hype cycle rages on, the question of user experience is becoming increasingly important, health care dealmakers said at the Axios BFD yesterday.Why it matters: Companies can spend millions developing new AI tools, but it&#x27;s all moot if physicians and patients can&#x27;t practically use them.

topics

politics-policy

epstein-files

donald-trump

2026-midterm-elections

immigration

behind-the-curtain

race-and-equity

technology

privacy-tech-regulation

automation-and-ai

tiktok-news

big-tech

social-media

cybersecurity

economy

social-security

inflation

tariffs

federal-reserve

jobs

transportation

business

stock-market-news

retail-news

crypto

media

elon-musk

dealmaking

health

rfk-jr

drug-prices

axios-explains-abortion

public-health

world

israel

axios-explains-ukraine

iran

russia

china

energy-climate

nuclear-energy

climate-energy-policy

climate-change

extreme-weather

alternative-energy

electric-vehicles

science

emerging-tech

biomedicine

newsletters

charlotte

boulder

detroit

kansas-city

columbus

austin

dallas

atlanta

washington-dc

nw-arkansas

chicago

indianapolis

nashville

richmond

colorado-springs

houston

san-francisco

seattle

boston

des-moines

salt-lake-city

philadelphia

denver

phoenix

new-orleans

miami

twin-cities

raleigh

san-antonio

portland

san-diego

tampa-bay

cleveland

huntsville

pittsburgh

axios-local

axios-pro

axios-live

the-axios-show

Health care dealmakers talk end-user for AI

What to read next